person · Reporting owner
Schaeffer Orlov S Nicole
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INSMED IncINSM · Entity 3174 | Chief People Strategy Officer | January 02, 2026 | January 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INSMED Inc
Report date January 02, 2026 · Filed January 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 41,754 |
Ending reported balance
After 2026-01-02 transaction · row 7
7 source rows · reconciled sequenceRow 1 · 2026-01-02 · Grant · Acquired 5,293 · Balance 41,754 F1: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested. F2: Each RSU was granted on January 2, 2026 for no consideration. Row 2 · 2026-01-02 · Exercise / conversion · Acquired 87,290 · Balance 129,044 F3: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 29, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Row 3 · 2026-01-02 · Sale · Disposed 31,030 · Balance 98,014 F3: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 29, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4: This is the weighted average sales price representing 31,030 shares sold at prices ranging from $173.67 to $174.66 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Row 4 · 2026-01-02 · Sale · Disposed 34,103 · Balance 63,911 F3: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 29, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F5: This is the weighted average sales price representing 34,103 shares sold at prices ranging from $174.67 to $175.65 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Row 5 · 2026-01-02 · Sale · Disposed 12,832 · Balance 51,079 F3: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 29, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F6: This is the weighted average sales price representing 12,832 shares sold at prices ranging from $175.67 to $176.62 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Row 6 · 2026-01-02 · Sale · Disposed 9,125 · Balance 41,954 F3: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 29, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F7: This is the weighted average sales price representing 9,125 shares sold at prices ranging from $176.68 to $177.67 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Row 7 · 2026-01-02 · Sale · Disposed 200 · Balance 41,754 F3: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 29, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F8: This is the weighted average sales price representing 200 shares sold at prices ranging from $177.72 to $177.84 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $177.12 · Expires 2036-01-02 | Direct | 27,600 |
Reported balance
After 2026-01-02 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-01-02 · Grant · Acquired 27,600 · Balance 27,600 F9: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.91 · Expires 2029-01-03 | Direct | 0 |
Reported balance
After 2026-01-02 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-01-02 · Exercise / conversion · Disposed 87,290 · Balance 0 F3: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 29, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F10: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.
F2: Each RSU was granted on January 2, 2026 for no consideration.
F3: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 29, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F4: This is the weighted average sales price representing 31,030 shares sold at prices ranging from $173.67 to $174.66 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F5: This is the weighted average sales price representing 34,103 shares sold at prices ranging from $174.67 to $175.65 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F6: This is the weighted average sales price representing 12,832 shares sold at prices ranging from $175.67 to $176.62 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F7: This is the weighted average sales price representing 9,125 shares sold at prices ranging from $176.68 to $177.67 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F8: This is the weighted average sales price representing 200 shares sold at prices ranging from $177.72 to $177.84 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F9: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested.
F10: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 01, 2021 Filed Nov 3, 2021 20:27 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 340 | $31.08 | $10,567.20 |
DisclosureSEC source: 0001140361-21-036424 · form4.xml · nonDerivative · entry 3 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,514 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: This is the weighted average sales price representing 340 shares sold at prices ranging from $31.00 to $31.14 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:27 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 60,660 | $30.28 | $1,836,784.80 |
DisclosureSEC source: 0001140361-21-036424 · form4.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,854 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: This is the weighted average sales price representing 60,660 shares sold at prices ranging from $30.00 to $30.99 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:27 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 61,000 | $12.44 | $758,840.00 |
DisclosureSEC source: 0001140361-21-036424 · form4.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,514 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · balance_after: Includes 722 shares acquired through the Company's 2018 Employee Stock Purchase Plan. Read SEC document |
| May 15, 2021 Filed May 18, 2021 20:36 UTC | INSMED Inc INSM · Entity 3174 | Tax withholdingCommon Stock | 1,806 | $26.23 | $47,371.38 |
DisclosureSEC source: 0001140361-21-017891 · form4.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,792 F1 · shares: Shares withheld by the Company to satisfy tax withholding requirements on vesting of time-based restricted stock units. Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:56 UTC | INSMED Inc INSM · Entity 3174 | GrantStock Option (right to buy) · Derivative | 45,760 | $0.00 Strike: $26.46 | $0.00 |
DisclosureSEC source: 0001140361-21-017444 · form4.xml · derivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,760 Underlying: Common Stock · 45,760 shares Expires 2031-05-12 F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:56 UTC | INSMED Inc INSM · Entity 3174 | GrantCommon Stock | 9,448 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-017444 · form4.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,598 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on May 12, 2021, for no consideration. Read SEC document |
| March 08, 2021 Filed Mar 12, 2021 21:10 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 4,709 | $0.00 Strike: $20.49 | $0.00 |
DisclosureSEC source: 0001140361-21-008313 · form4.xml · derivative · entry 3 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,791 Underlying: Common Stock · 4,709 shares Expires 2024-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Stock options granted under the Company's 2013 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| March 08, 2021 Filed Mar 12, 2021 21:10 UTC | INSMED Inc INSM · Entity 3174 | Tax withholdingCommon Stock | 2,479 | $38.92 | $96,482.68 |
DisclosureSEC source: 0001140361-21-008313 · form4.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,150 Read SEC document |
| March 08, 2021 Filed Mar 12, 2021 21:10 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 4,709 | $20.49 | $96,487.41 |
DisclosureSEC source: 0001140361-21-008313 · form4.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,629 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 07, 2021 Filed Jan 8, 2021 21:38 UTC | INSMED Inc INSM · Entity 3174 | GrantStock Option (right to buy) · Derivative | 36,480 | $0.00 Strike: $34.03 | $0.00 |
DisclosureSEC source: 0001104659-21-002506 · tm211774-9_4seq1.xml · derivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,480 Underlying: Common Stock · 36,480 shares Expires 2031-01-07 F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| January 07, 2021 Filed Jan 8, 2021 21:38 UTC | INSMED Inc INSM · Entity 3174 | GrantCommon Stock | 7,346 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-002506 · tm211774-9_4seq1.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,920 F1 · shares: Restricted stock units granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on January 7, 2021, for no consideration, and represents a contingent right to receive one share of Common Stock. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 22:12 UTC | INSMED Inc INSM · Entity 3174 | Tax withholdingCommon Stock | 910 | $33.42 | $30,412.20 |
DisclosureSEC source: 0001104659-21-001602 · tm211774-2_4seq1.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,574 F1 · shares: Shares withheld by the Company to satisfy tax withholding requirements on vesting of time-based restricted stock units. Read SEC document |
| January 03, 2021 Filed Jan 6, 2021 22:12 UTC | INSMED Inc INSM · Entity 3174 | Tax withholdingCommon Stock | 949 | $33.29 | $31,592.21 |
DisclosureSEC source: 0001104659-21-001602 · tm211774-2_4seq1.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,484 F1 · shares: Shares withheld by the Company to satisfy tax withholding requirements on vesting of time-based restricted stock units. F2 · balance_after: Includes 206 shares acquired through the Company's 2018 Employee Stock Purchase Plan. Read SEC document |
| August 12, 2020 Filed Aug 13, 2020 20:11 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $12.44 | $0.00 |
DisclosureSEC source: 0001104659-20-094674 · a4.xml · derivative · entry 10 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,500 Underlying: Common Stock · 4,000 shares Expires 2023-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: On May 23, 2013, the reporting person was granted an option to purchase 25,000 shares of common stock. The option vests in two installments based upon the Issuer's satisfaction of two separate performance metrics. The first installment vested on February 26, 2015. The performance metric applicable to the second installment, the first written approval of a New Drug Application or Marketing Authorization Application from the Food and Drug Administration of European Medicines Agency, respectively, was met on September 28, 2018, resulting in the vesting of the second installment. Read SEC document |
| August 12, 2020 Filed Aug 13, 2020 20:11 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 465 | $0.00 Strike: $6.96 | $0.00 |
DisclosureSEC source: 0001104659-20-094674 · a4.xml · derivative · entry 9 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 465 shares Expires 2023-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| August 12, 2020 Filed Aug 13, 2020 20:11 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 4,000 | $28.80 | $115,200.00 |
DisclosureSEC source: 0001104659-20-094674 · a4.xml · nonDerivative · entry 7 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,227 F4 · price: This is the weighted average sales price representing 4,000 shares sold at prices ranging from $28.71 to $28.95 per share. The number sold at each price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| August 12, 2020 Filed Aug 13, 2020 20:11 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 4,000 | $12.44 | $49,760.00 |
DisclosureSEC source: 0001104659-20-094674 · a4.xml · nonDerivative · entry 6 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,227 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 12, 2020 Filed Aug 13, 2020 20:11 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 465 | $28.77 | $13,378.05 |
DisclosureSEC source: 0001104659-20-094674 · a4.xml · nonDerivative · entry 5 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,227 F3 · price: This is the weighted average sales price representing 465 shares sold at prices ranging from $28.75 to $28.79 per share. The number sold at each price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| August 12, 2020 Filed Aug 13, 2020 20:11 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 465 | $6.96 | $3,236.40 |
DisclosureSEC source: 0001104659-20-094674 · a4.xml · nonDerivative · entry 4 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,692 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 11, 2020 Filed Aug 13, 2020 20:11 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 3,761 | $0.00 Strike: $6.96 | $0.00 |
DisclosureSEC source: 0001104659-20-094674 · a4.xml · derivative · entry 8 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 465 Underlying: Common Stock · 3,761 shares Expires 2023-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| August 11, 2020 Filed Aug 13, 2020 20:11 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 3,761 | $30.07 | $113,093.27 |
DisclosureSEC source: 0001104659-20-094674 · a4.xml · nonDerivative · entry 3 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,227 F2 · price: This is the weighted average sales price representing 3,761 shares sold at prices ranging from $30.00 to $30.45 per share. The number sold at each price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| August 11, 2020 Filed Aug 13, 2020 20:11 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 3,761 | $6.96 | $26,176.56 |
DisclosureSEC source: 0001104659-20-094674 · a4.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,988 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2020 Filed Aug 13, 2020 20:11 UTC | INSMED Inc INSM · Entity 3174 | Tax withholdingCommon Stock | 1,126 | $25.46 | $28,667.96 |
DisclosureSEC source: 0001104659-20-094674 · a4.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,227 F1 · security: Represents the withholding of shares of common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. This transaction was not reported previously due to a clerical error. Read SEC document |
| January 03, 2020 Filed Jan 7, 2020 23:13 UTC | INSMED Inc INSM · Entity 3174 | GrantStock Option (right to buy) · Derivative | 56,520 | $0.00 Strike: $23.75 | $0.00 |
DisclosureSEC source: 0001127430-20-000026 · edgar.xml · derivative · entry 3 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,520 Underlying: Common Stock · 56,520 shares Expires 2030-01-03 F5 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| January 03, 2020 Filed Jan 7, 2020 23:13 UTC | INSMED Inc INSM · Entity 3174 | Tax withholdingCommon Stock | 979 | $23.75 | $23,251.25 |
DisclosureSEC source: 0001127430-20-000026 · edgar.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,552 F4 · price: Shares withheld by the Company to satisfy tax withholding requirements on vesting of time-based restricted stock units. Read SEC document |
| January 03, 2020 Filed Jan 7, 2020 23:13 UTC | INSMED Inc INSM · Entity 3174 | GrantCommon Stock | 10,526 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127430-20-000026 · edgar.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,531 F1 · shares: Restricted stock units granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on January 3, 2020, for no consideration, and represents a contingent right to receive one share of Common Stock. F3 · balance_after: Includes 1,655 shares acquired through the Company's 2018 Employee Stock Purchase Plan. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 20:05 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $6.96 | $0.00 |
DisclosureSEC source: 0001127430-19-000083 · edgar.xml · derivative · entry 3 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,226 Underlying: Common Stock · 12,000 shares Expires 2023-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Stock options granted under the Company's 2000 Incentive Plan. These stock options are currently exercisable. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 20:05 UTC | INSMED Inc INSM · Entity 3174 | SaleStock Option | 12,000 | $23.24 | $278,839.20 |
DisclosureSEC source: 0001127430-19-000083 · edgar.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,350 F1 · price: This is the weighted average sales price representing 12,000 shares sold at prices ranging from $23.00 to $23.66 per share. The number sold at each price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 20:05 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option | 12,000 | $6.96 | $83,520.00 |
DisclosureSEC source: 0001127430-19-000083 · edgar.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,350 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2019 Filed May 16, 2019 21:14 UTC | INSMED Inc INSM · Entity 3174 | GrantCommon Stock | 14,660 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127430-19-000071 · edgar.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,350 F1 · shares: Restricted stock units granted pursuant to the Company's 2017 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on May 15, 2019, for no consideration, and represents a contingent right to receive one share of Common Stock. Read SEC document |
| January 04, 2019 Filed Jan 7, 2019 21:10 UTC | INSMED Inc INSM · Entity 3174 | Tax withholdingCommon Stock | 979 | $14.85 | $14,538.15 |
DisclosureSEC source: 0001127430-19-000020 · edgar.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,690 F1 · price: Shares withheld by the Company to satisfy tax withholding requirements on vesting of time-based restricted stock units. Read SEC document |
| January 03, 2019 Filed Jan 7, 2019 21:10 UTC | INSMED Inc INSM · Entity 3174 | GrantStock Option · Derivative | 157,290 | $0.00 Strike: $13.91 | $0.00 |
DisclosureSEC source: 0001127430-19-000020 · edgar.xml · derivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,290 Underlying: Common Stock · 157,290 shares Expires 2029-01-03 F2 · derivative.exercise_date: Stock options granted under the Company's 2017 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| September 28, 2018 Filed Oct 2, 2018 20:11 UTC | INSMED Inc INSM · Entity 3174 | GrantStock Option · Derivative | 12,500 | $0.00 Strike: $12.44 | $0.00 |
DisclosureSEC source: 0001127430-18-000060 · edgar.xml · derivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2023-05-23 F1 · derivative.underlying_shares: On May 23, 2013, the reporting person was granted an option to purchase 25,000 shares of common stock. The option vests in two installments based upon the Issuer's satisfaction of two separate performance metrics. The first installment vested on February 26, 2015. The performance metric applicable to the second installment, the first written approval of a New Drug Application or Marketing Authorization Application from the Food and Drug Administration of European Medicines Agency, respectively, was met on September 28, 2018, resulting in the vesting of the second installment. Read SEC document |
| May 30, 2018 Filed May 31, 2018 20:05 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 25,991 | $0.00 Strike: $10.85 | $0.00 |
DisclosureSEC source: 0001127430-18-000050 · edgar.xml · derivative · entry 6 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,575 Underlying: Common Stock · 25,991 shares Expires 2026-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock options granted under the Company's 2015 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty-five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one-half percent (12.5%) vest on the six month anniversary of the first anniversary date and each six month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| May 30, 2018 Filed May 31, 2018 20:05 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 25,991 | $28.24 | $733,985.84 |
DisclosureSEC source: 0001127430-18-000050 · edgar.xml · nonDerivative · entry 4 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,669 F2 · price: This is the weighted average sales price representing 25,991 shares sold at prices ranging from $28.00 to $28.32 per share. The number sold at each price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| May 30, 2018 Filed May 31, 2018 20:05 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 25,991 | $10.85 | $282,002.35 |
DisclosureSEC source: 0001127430-18-000050 · edgar.xml · nonDerivative · entry 3 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,660 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 29, 2018 Filed May 31, 2018 20:05 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 11,584 | $0.00 Strike: $10.85 | $0.00 |
DisclosureSEC source: 0001127430-18-000050 · edgar.xml · derivative · entry 5 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,566 Underlying: Common Stock · 11,584 shares Expires 2026-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock options granted under the Company's 2015 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty-five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one-half percent (12.5%) vest on the six month anniversary of the first anniversary date and each six month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| May 29, 2018 Filed May 31, 2018 20:05 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 11,584 | $27.68 | $320,645.12 |
DisclosureSEC source: 0001127430-18-000050 · edgar.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,669 F1 · price: This is the weighted average sales price representing 11,584 shares sold at prices ranging from $27.60 to $27.84 per share. The number sold at each price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| May 29, 2018 Filed May 31, 2018 20:05 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 11,584 | $10.85 | $125,686.40 |
DisclosureSEC source: 0001127430-18-000050 · edgar.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,253 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2018 Filed Jan 8, 2018 21:11 UTC | INSMED Inc INSM · Entity 3174 | GrantStock Option · Derivative | 55,400 | $0.00 Strike: $30.46 | $0.00 |
DisclosureSEC source: 0001127430-18-000020 · edgar.xml · derivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · SVP, HR & Corp. Svcs. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,400 Underlying: Common Stock · 55,400 shares Expires 2028-01-04 F3 · derivative.exercise_date: Stock options granted under the Company's 2017 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| January 04, 2018 Filed Jan 8, 2018 21:11 UTC | INSMED Inc INSM · Entity 3174 | GrantCommon Stock | 10,669 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127430-18-000020 · edgar.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · SVP, HR & Corp. Svcs. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,669 F1 · shares: Restricted stock units granted pursuant to the Company's 2017 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on January 4, 2018, for no consideration, and represents a contingent right to receive one share of Common Stock. Read SEC document |
| May 17, 2017 Filed May 19, 2017 20:34 UTC | INSMED Inc INSM · Entity 3174 | GrantStock Option · Derivative | 38,300 | $0.00 Strike: $17.16 | $0.00 |
DisclosureSEC source: 0001127430-17-000050 · edgar.xml · derivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · SVP, HR & Corp. Svcs. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,300 Underlying: Common Stock · 38,300 shares Expires 2027-05-17 F1 · derivative.exercise_date: Stock options granted under the Company's 2015 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| January 05, 2017 Filed Jan 9, 2017 21:18 UTC | INSMED Inc INSM · Entity 3174 | GrantStock Option · Derivative | 41,140 | $0.00 Strike: $13.67 | $0.00 |
DisclosureSEC source: 0001127430-17-000012 · edgar.xml · derivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · SVP, HR & Corp. Svcs. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,140 Underlying: Common Stock · 41,140 shares Expires 2027-01-05 F1 · derivative.exercise_date: Stock options granted under the Company's 2015 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| November 09, 2016 Filed Nov 9, 2016 21:31 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option · Derivative | 8,009 | $0.00 Strike: $6.96 | $0.00 |
DisclosureSEC source: 0001127430-16-000155 · edgar.xml · derivative · entry 9 Schaeffer Orlov S Nicole · CIK 0001401017 · SVP, HR & Corp. Svcs. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,009 shares Expires 2023-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Stock options granted under the Company's 2000 Stock Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| November 09, 2016 Filed Nov 9, 2016 21:31 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 8,009 | $13.25 | $106,119.25 |
DisclosureSEC source: 0001127430-16-000155 · edgar.xml · nonDerivative · entry 6 Schaeffer Orlov S Nicole · CIK 0001401017 · SVP, HR & Corp. Svcs. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| November 09, 2016 Filed Nov 9, 2016 21:31 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 8,009 | $6.96 | $55,742.64 |
DisclosureSEC source: 0001127430-16-000155 · edgar.xml · nonDerivative · entry 5 Schaeffer Orlov S Nicole · CIK 0001401017 · SVP, HR & Corp. Svcs. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,009 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2016 Filed Nov 9, 2016 21:31 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option · Derivative | 23,265 | $0.00 Strike: $6.96 | $0.00 |
DisclosureSEC source: 0001127430-16-000155 · edgar.xml · derivative · entry 8 Schaeffer Orlov S Nicole · CIK 0001401017 · SVP, HR & Corp. Svcs. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,009 Underlying: Common Stock · 23,265 shares Expires 2023-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Stock options granted under the Company's 2000 Stock Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| November 07, 2016 Filed Nov 9, 2016 21:31 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option · Derivative | 37,500 | $0.00 Strike: $6.96 | $0.00 |
DisclosureSEC source: 0001127430-16-000155 · edgar.xml · derivative · entry 7 Schaeffer Orlov S Nicole · CIK 0001401017 · SVP, HR & Corp. Svcs. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,226 Underlying: Common Stock · 37,500 shares Expires 2023-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Stock options granted under the Company's 2000 Stock Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| November 07, 2016 Filed Nov 9, 2016 21:31 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 23,265 | $11.78 | $274,061.70 |
DisclosureSEC source: 0001127430-16-000155 · edgar.xml · nonDerivative · entry 4 Schaeffer Orlov S Nicole · CIK 0001401017 · SVP, HR & Corp. Svcs. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price in column 4 is a weighted average price. The prices in these transactions range from $11.75 to $11.91. Read SEC document |
| November 07, 2016 Filed Nov 9, 2016 21:31 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 23,265 | $6.96 | $161,924.40 |
DisclosureSEC source: 0001127430-16-000155 · edgar.xml · nonDerivative · entry 3 Schaeffer Orlov S Nicole · CIK 0001401017 · SVP, HR & Corp. Svcs. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,265 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.